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ABSTRACT
Objective: This study aimed to determine the hepatoprotective effect of 50% ethanol extract of seagrass rhizome in terms of serum glutamic 
oxaloacetic transaminase (SGOT) and serum glutamic pyruvic transaminase (SGPT) activities in paracetamol-induced rat plasma.
Methods: This study included 28 male, white rats randomly divided into seven groups. Groups I and II represented the normal control and control 
groups, respectively, administered with 280 mg/kg BW of rhizome extract. Group III represented the negative control group induced by a suspension 
of paracetamol (2g/kg BW). Group IV represented a positive control group administered with Hepa-Q® at a dosage of 150 mg/kg BW. Groups V, VI, 
and VII were administered with seagrass rhizome extract at doses of 140, 280, and 560 mg/kg BW, respectively, before paracetamol induction. The 
test material was orally administered for 17 days. On days 12–17, the rats were induced with paracetamol through the same route. On day 18, blood 
sampling was performed followed by SGOT and SGPT plasma measurements.
Results: Our results revealed that seagrass rhizome extracts could significantly decrease SGPT and SGOT levels in paracetamol-induced rats (p<0.05) 
compared with those in the negative control group.
Conclusion: Thus, seagrass rhizome extracts possess the potential for development as a hepatoprotective agent.
Keywords: Seagrass rhizome, Hepatoprotective, Paracetamol, Serum glutamic oxaloacetic transaminase, Serum glutamic pyruvic transaminase.
INTRODUCTION
Liver is a vital organ for survival, and it contributes to almost every 
metabolic function of the body [1]. In addition to playing an important 
role in the metabolism of carbohydrates, proteins, and fats, the liver 
also plays a role in the storage of vitamins, iron, and copper as well as 
in the detoxification of a large number of endogenous and exogenous 
substances [1]. The liver is involved in the synthesis, storage, and 
metabolism of several endogenous compounds and the clearance of 
exogenous compounds, including drugs and toxins from the body [2]. 
Liver damage can include fatty liver, necrosis, cholestasis, hepatitis, and 
liver cirrhosis [1]. Damage to the liver can be overcome by preventive 
(hepatoprotective) and curative (antihepatotoxic) efforts [3].
Based on these backgrounds, the liver needs to be maintained to 
function properly. Conventional drug therapy for various liver damage 
diseases, such as non-alcoholic fatty liver disease and viral hepatitis, 
has limited efficacy and potentially adverse effects. Treatment using 
extracts derived from natural resources, such as plants, is considered to 
be the best method to maintain liver functions in the long-term without 
significantly inducing toxic effects [4].
Indonesia is a country with a vast maritime territory, and hence, it is 
called a maritime country. Indonesia’s marine biota has great potential 
for exploration, particularly in the field of health. One of the marine biotas 
that can be used for health is the seagrass rhizome (Cymodocea rotundata). 
Seagrass rhizome is a dominant species of seagrass that is easily found in 
almost all Indonesian waters. Seagrass rhizome possesses high productivity 
in Indonesia but has not been matched by optimal utilization [5]. The 
utilization of seagrass rhizomes as a hepatoprotective agent is one way to 
improve optimization of seagrass utilization in the field of health.
Based on previous studies, seagrass rhizome is believed to possess 
high antioxidant content, which is indicated by a good IC50 value, as 
analyzed by the 1, 1-diphenyl-β-picrylhydrazyl-scavenging activity 
(8±0.745) and ferric-reducing antioxidant power method (1.39±0.32). 
The antioxidant content is an important parameter that determines the 
hepatoprotective activity. Considering the high antioxidant content in 
seagrass rhizomes, it is necessary to test the hepatoprotective effect 
of seagrass rhizome on the liver. Research on the hepatoprotective 
effect of seagrass rhizomes was conducted to determine the ability 
of seagrass rhizomes to prevent or protect the liver from damage. 
Parameters observed included aspartate aminotransferase and alanine 
aminotransferase (serum glutamic oxaloacetic transaminase [SGOT] 
and serum glutamic pyruvic transaminase [SGPT], respectively) 
activities in the blood plasma. Liver cells containing various enzymes, 
such as SGOT and SGPT, are important for the diagnosis of liver damage 
because the enzyme is passed into the blood vessels. Estimation of 
enzyme activity may thus indicate the presence of liver disease [6].
METHODS
Seagrass rhizome extracts
Seagrass rhizomes were obtained from the Thousand Islands, Jakarta. 
The voucher specimen was deposited at Center for Plant Conservation 
Botanic Gardens. Dry powdered seagrass rhizome (50 kg) was 
macerated with 50 L of 50% ethanol for 5×24 h with continuous 
shaking. The maceration was repeatedly performed until the collected 
filtrate was colorless. The final filtered product was then evaporated 
with the solvent using a rotary evaporator with a vacuum pump, after 
which the obtained extract was concentrated by placing on a water bath 
at approximately 50°C to obtain a viscous extract. Since the marine 
natural material has a high salt content, the viscous extract obtained 
was centrifuged at 6000 rpm for 15 min [7].
Identification of flavonoids in seagrass rhizome extracts
A total of ±0.2 g of the obtained extract was added to 50 mL of hot 
water and then boiled for 5 min, followed by filtration to obtain a 
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filtrate, which was used as the experimental solution. To 5 mL of the 
experimental solution, mg powder and 1 mL of concentrated HCl were 
added. Next, amyl alcohol was added, and the mixture was vigorously 
shaken to allow separation. The development of red, yellow, or orange 
color in the amyl alcohol solution indicated the presence of flavonoid 
group compounds [8].
Experimental animals
This study was approved by the Ethics Committee of Faculty of 
Medicine, Universitas Indonesia (No. 154/UN2.F1/ETIK/2018). 
Male, white Sprague-Dawley rats (Rattus norvegicus) were used as 
the experimental animals. The animals were approximately 2 months 
old with a body weight of 150–200 g. The experimental animals were 
acclimatized for 1 week and then observed daily by monitoring weight 
gain and health conditions.
Experimental animal treatment
The experimental animals were randomly divided into seven groups. The 
test animals were treated for 17 days; on day 12 until day 17, the animals 
were induced with paracetamol and their blood was collected on day 18. 
Table 1 shows the experimental scheme that was planned. Note that the 
colored block means there is an experiment given to the mentioned group.
Determination of SGOT and SGPT plasma levels
SGOT and SGPT blood activities were determined using the kinetic 
principle established by the International Federation of Chemical 
Chemistry using a UV-Vis spectrophotometer. Plasma (50 μL) of 
the experimental animals was obtained on day 18 and mixed with 
1000 μL of SGOT and SGPT reagents and then vortexed and incubated 
at 37°C for 1 min followed by measurement of absorbance using a 
spectrophotometer at 340 nm wavelength for SGOT and SGPT activities. 
The sample absorbance measurements were performed for 3 min with 
recorded uptake at the 1st, 2nd, and 3rd min. Results of SGOT and SGPT 
activities are expressed in units/liter (U/L). SGOT and SGPT activities 
were calculated using the following formula; activity SGOT/SGPT (U/L) 
37°C=ΔA/min×1746 (conversion factor).
Data analysis
Data obtained were statistically processed using SPSS 24.0. The first 
analysis was the normality test (Shapiro–Wilk Test) and homogeneity 
test (Levene test). The analysis was then continued by one-way analysis 
of variance to examine the relationship among all treatment groups 
as well as to determine whether data were normally distributed 
and homogeneous. Then, the analysis continued with the smallest 
differential differences test Boston naming test to evaluate differences 
among the treatment groups. The Kruskal–Wallis test was performed 
for evaluating the relationship among all treatment groups and for 
testing whether data were normally distributed and homogeneous. 
Then, the analysis was continued with the Mann–Whitney U-test 
to examine differences among the treatment groups. Tests were 
performed to determine significant differences between two unrelated 
treatment groups by independent t-test and to examine whether data 
were normally distributed and homogeneous.
RESULTS
Identification of flavonoids in seagrass rhizome extract
The flavonoids test on seagrass rhizome extract revealed positive 
results, which were indicated by the formation of yellow-orange color 
in the amyl alcohol layer.
Measurement results of SGOT and SGPT
Fig. 1 shows Seagrass rhizome extracts effect profile on SGPT and SGPT 
levels. As shown in Table 2, Group I showed significantly lower SGOT 
levels than Group III (p<0.05), which indicates that the mean SGOT level 
was 73.05 U/L in Group I and 153.44 U/L in Group III. The SGOT level 
in Group I in the normal range according to Girindra (1989), that is, 
45.7–80.8 U/L, whereas that of Group III was above the normal range. 
Group III showed the significantly highest SGOT level compared with 
all other groups (p<0.05). Group IV showed significantly lower SGOT 
levels than Group III (p<0.05), but higher and insignificant level than 
Groups I, II, and VI. Group II showed the lowest average SGOT levels 
among all other groups. The group of dose variations showing an 
average SGOT level closest to that of Group I (normal) was Group VI. 
In addition, Group VI tended to show lower SGOT levels than the group 
administered with the Hepa-Q drug.
As seen in Table 2, Group I showed significantly lower SGPT level 
(29.39 U/L) than Group III (111.89 U/L) (p<0.05). SGPT levels in 
Group I were in the normal range, according to Girindra (1989), that 
is, it ranged from 17 to 30.2 U/L. Group III had the highest levels of 
SGPT significantly compare to all other groups (p<0.05), with the 
average SGPT level being above the normal levels. Group IV showed 
significantly lower SGPT levels than Group III, but significantly higher 
levels than Group I (p<0.05). Group II showed the lowest average SGPT 
Fig. 1: Seagrass rhizome extracts effect profile on serum glutamic 
pyruvic transaminase and serum glutamic pyruvic transaminase 
levels
Table 1: Experimental scheme
Treatment Group
I II III IV V VI VI
Treatment (day 1–17)
CMC 0.5%
Hepa-Q® (150 mg/kg BW)
Seagrass extract dose 1 (140 mg/kg BW)
Seagrass extract dose 2 (280 mg/kg BW)
Seagrass extract dose 3 (560 mg/kg BW)
Hepatotoxic induction (day 12–17) (paracetamol 2 g/kg BW)
Blood collection (day 18)
Description: Group I: Normal group, Group II: Control group administered the extract (280 mg/kg BW, orally), Group III: Negative control group, Group IV: Positive 
control group (Hepa-Q® at 150 mg/kg BW, orally), Group V: Test group administered with the seagrass rhizome extract dose 1 (140 mg/kg BW, orally), Group VI: Test 
group administered with the seagrass rhizome extract dose 2 (280 mg/kg BW, orally), and Group VII: Test group administered with the seagrass rhizome extract dose 
3 (560 mg/kg BW, orally)
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levels among all other groups. The group of dose variations with an 
average SGOT level closest to that of the normal group was Group VI. 
In addition, Group VI tended to show lower larger SGOT levels than the 
group administered with the Hepa-Q drug.
DISCUSSION
Group I comprised rats under normal conditions, that is, with SGOT 
and SGPT levels in the normal range probably because this group was 
not induced by paracetamol and, therefore, paracetamol-induced liver 
damage did not occur. Group III was induced with paracetamol without 
administration of medication or seagrass rhizome extract, and it 
showed the highest SGOT and SGPT levels at a level significantly higher 
than that of all other groups (p<0.05). This result can be explained 
by Goodman and Gilman’s [9] statement that when paracetamol is 
consumed in high doses, it is metabolized through the cytochrome 
P450, which spontaneously converts paracetamol N-hydroxylated to 
form a hepatotoxic N-acetyl-p-benzoquinone imine metabolite that 
has the potential to cause heart damage. SGPT and SGOT levels in the 
blood plasma increase in case of damage to liver cells. SGPT and SGOT 
enzymes are transaminase-class enzymes that can be found in the liver 
and serve as sensitive indicators of liver cell damage [10].
Group IV rats could significantly lower their plasma SGOT and SGPT 
levels as compared with Group III rats, which suggest that Hepa-Q 
drug administered in Group IV significantly lowered SGOT levels in 
paracetamol-induced mice. The group administered with seagrass 
rhizome extracts showed decreased blood plasma SGOT and SGPT 
levels because its flavonoid compounds had potentially high antioxidant 
activity. Seagrass rhizome is known to possess the best antioxidant 
activity compared with other seagrass species because it has high 
flavonoid levels. Antioxidant content is an important parameter that 
determines the hepatoprotective activity [11].
CONCLUSION
Based on the research, it can be concluded that 50% ethanol extract 
of seagrass rhizome can significantly decrease SGPT and SGOT levels 
in paracetamol-induced rats (p<0.05), with the effective dose of 
280 mg/kg BW. Our results suggest that this extract can be developed 
into an hepatoprotective agent.
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Table 2: Examined SGOT and SGPT levels
Treatment Mean±SD
I II III IV V VI VII
SGOT levels (U/L) 73.05*±9.42 70.09*±3.79 153.44#±59.06 86.57*±19.42 97.01*±10.56 77.43*±11.59 95.72*±19.73
SGPT levels (U/L) 29.39*±1.539 27.79*±2.94 111.89#±42.14 58.05*#±8.29 35.65*±2.25 30.56*±2.79 36.38*±0.75
Description: Group I: Normal group, Group II: Control group administered the extract (280 mg/kg BW, orally), Group III: Negative control group, Group IV: Positive 
control group (Hepa-Q® at 150 mg/kgBW, orally), Group V: Test group administered with the seagrass rhizome extract dose 1 (140 mg/kg BW, orally), Group VI: Test 
group administered with the seagrass rhizome extract dose 2 (280 mg/kg BW, orally), and Group VII: Test group administered with the seagrass rhizome extract dose 
3 (560 mg/kg BW, orally). #Significantly differed from the normal control group (p<0.05); *Significantly differed from the negative control group (p<0.05).
SGOT: Serum glutamic oxaloacetic transaminase, SGPT: Serum glutamic pyruvic transaminase, SD: Standard deviation
